1. Home
  2. MRKR vs PLAG Comparison

MRKR vs PLAG Comparison

Compare MRKR & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • PLAG
  • Stock Information
  • Founded
  • MRKR N/A
  • PLAG 1986
  • Country
  • MRKR United States
  • PLAG United States
  • Employees
  • MRKR N/A
  • PLAG N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • MRKR Health Care
  • PLAG Consumer Staples
  • Exchange
  • MRKR Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • MRKR 19.1M
  • PLAG 17.1M
  • IPO Year
  • MRKR N/A
  • PLAG N/A
  • Fundamental
  • Price
  • MRKR $1.47
  • PLAG $0.82
  • Analyst Decision
  • MRKR Strong Buy
  • PLAG
  • Analyst Count
  • MRKR 3
  • PLAG 0
  • Target Price
  • MRKR $13.17
  • PLAG N/A
  • AVG Volume (30 Days)
  • MRKR 231.4K
  • PLAG 862.4K
  • Earning Date
  • MRKR 08-13-2025
  • PLAG 08-13-2025
  • Dividend Yield
  • MRKR N/A
  • PLAG N/A
  • EPS Growth
  • MRKR N/A
  • PLAG N/A
  • EPS
  • MRKR N/A
  • PLAG N/A
  • Revenue
  • MRKR $5,696,123.00
  • PLAG $6,066,143.00
  • Revenue This Year
  • MRKR N/A
  • PLAG N/A
  • Revenue Next Year
  • MRKR $11.28
  • PLAG N/A
  • P/E Ratio
  • MRKR N/A
  • PLAG N/A
  • Revenue Growth
  • MRKR 71.53
  • PLAG N/A
  • 52 Week Low
  • MRKR $0.95
  • PLAG $0.47
  • 52 Week High
  • MRKR $5.99
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 50.81
  • PLAG 34.81
  • Support Level
  • MRKR $1.41
  • PLAG $0.75
  • Resistance Level
  • MRKR $1.53
  • PLAG $0.92
  • Average True Range (ATR)
  • MRKR 0.16
  • PLAG 0.44
  • MACD
  • MRKR -0.03
  • PLAG -0.21
  • Stochastic Oscillator
  • MRKR 9.43
  • PLAG 14.28

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: